Literature DB >> 14517686

Neoadjuvant radiation and chemotherapy in rectal cancer does not increase postoperative complications.

G Valero1, J A Luján, Q Hernández, M De Las Heras, E Pellicer, A Serrano, P Parrilla.   

Abstract

BACKGROUND AND AIMS: Neoadjuvant radiation and chemotherapy in rectal cancer reduces local recurrences and increases the rate of conservative sphincter surgery. However, an increase in postoperative morbidity and mortality has also been observed. This study analyzed the operative difficulty and postoperative complications in patients with this treatment. PATIENTS AND METHODS: Retrospective review of 103 patients with rectal cancer, divided into two groups: group A, 53 patients undergoing preoperative radiotherapy with 45 Gy combined with chemotherapy, and group B, 50 patients with rectal cancer who received surgery after diagnosis. Both groups were homogeneous. The two groups were compared for both technical difficulty, using intraoperative data and rate of complications.
RESULTS: There were no statistically significant differences between the two groups with regard to intraoperative or postoperative data. In group A there were 20 complications in 17 patients (32%) and in group B 22 complications in 19 patients (38%). The rates of perineal wound infection were similar. The percentage of anastomotic leaks was higher in group A. A greater number of anterior resections was performed in group A.
CONCLUSION: Preoperative radiation and chemotherapy in rectal cancer does not increase postoperative complications and increases the rate of sphincter-preserving surgery.

Entities:  

Mesh:

Year:  2003        PMID: 14517686     DOI: 10.1007/s00384-003-0520-1

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  18 in total

1.  Preoperative radiotherapy for resectable rectal cancer: A meta-analysis.

Authors:  C Cammà; M Giunta; F Fiorica; L Pagliaro; A Craxì; M Cottone
Journal:  JAMA       Date:  2000 Aug 23-30       Impact factor: 56.272

2.  Preoperative radiotherapy in operable rectal cancer.

Authors:  A Horn; J F Halvorsen; O Dahl
Journal:  Dis Colon Rectum       Date:  1990-10       Impact factor: 4.585

3.  Proposed classification of complications of surgery with examples of utility in cholecystectomy.

Authors:  P A Clavien; J R Sanabria; S M Strasberg
Journal:  Surgery       Date:  1992-05       Impact factor: 3.982

4.  Pre- or postoperative radiotherapy in rectal and rectosigmoid carcinoma. Report from a randomized multicenter trial.

Authors:  L Påhlman; B Glimelius
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

5.  Is anterior resection of the rectosigmoid safe after preoperative radiation?

Authors:  S H Roberson; H C Heron; H D Kerman; T S Bloom
Journal:  Dis Colon Rectum       Date:  1985-04       Impact factor: 4.585

6.  Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Medical Research Council Rectal Cancer Working Party.

Authors: 
Journal:  Lancet       Date:  1996-12-14       Impact factor: 79.321

7.  Locally advanced rectal cancer: surgical complications after infusional chemotherapy and radiation therapy.

Authors:  N A Janjan; V S Khoo; T A Rich; P A Evetts; M S Goswitz; P K Allen; J M Skibber
Journal:  Radiology       Date:  1998-01       Impact factor: 11.105

8.  Preoperative chemotherapy and radiation therapy for locally advanced primary and recurrent rectal carcinoma. A report of surgical morbidity.

Authors:  C R Shumate; T A Rich; J M Skibber; J A Ajani; D M Ota
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

9.  Postoperative mortality in rectal cancer treated with or without preoperative radiotherapy: causes and risk factors.

Authors:  T Holm; L E Rutqvist; H Johansson; B Cedermark
Journal:  Br J Surg       Date:  1996-07       Impact factor: 6.939

10.  Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum.

Authors:  R S Chari; D S Tyler; M S Anscher; L Russell; B M Clary; J Hathorn; H F Seigler
Journal:  Ann Surg       Date:  1995-06       Impact factor: 12.969

View more
  15 in total

1.  Evaluating toxicity in neoadjuvant radio-chemotherapy of rectal cancer.

Authors:  Stefan Höcht
Journal:  Int J Colorectal Dis       Date:  2003-07-15       Impact factor: 2.571

2.  Complications of perineal surgery.

Authors:  James W Ogilvie; Rocco Ricciardi
Journal:  Clin Colon Rectal Surg       Date:  2009-02

3.  Neoadjuvant chemoradiotherapy, sepsis and neutrophil levels following radical excision of rectal cancer.

Authors:  Aneel Bhangu; Peter Nightingale; Darren Daniels; Raju Tiramula
Journal:  Int J Colorectal Dis       Date:  2010-02-23       Impact factor: 2.571

4.  [Anastomotic leakage in the gastrointestinal tract-repair and prognosis].

Authors:  M Stumpf; U Klinge; P R Mertens
Journal:  Chirurg       Date:  2004-11       Impact factor: 0.955

5.  Single versus double stapling anastomotic technique in rectal cancer surgery.

Authors:  Z Radovanovic; T Petrovic; D Radovanovic; M Breberina; A Golubovic; D Lukic
Journal:  Surg Today       Date:  2013-06-26       Impact factor: 2.549

6.  Short-term preoperative radiotherapy is a safe approach for treatment of locally advanced rectal cancer.

Authors:  D P Korkolis; G D Plataniotis; E Gondikakis; D Xinopoulos; G V Koulaxouzidis; J Katsilieris; P P Vassilopoulos
Journal:  Int J Colorectal Dis       Date:  2005-06-10       Impact factor: 2.571

7.  A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy.

Authors:  Katherine E Poruk; Joseph A Lin; Michol A Cooper; Jin He; Martin A Makary; Kenzo Hirose; John L Cameron; Timothy M Pawlik; Christopher L Wolfgang; Frederic Eckhauser; Matthew J Weiss
Journal:  HPB (Oxford)       Date:  2016-09-10       Impact factor: 3.647

Review 8.  Anastomotic leakage after low anterior resection for rectal cancer: facts, obscurity, and fiction.

Authors:  Panagiotis Taflampas; Manousos Christodoulakis; Dimitrios D Tsiftsis
Journal:  Surg Today       Date:  2009-03-12       Impact factor: 2.549

9.  Tumor response to neoadjuvant chemoradiation in rectal cancer: predictor for surgical morbidity?

Authors:  K Horisberger; R D Hofheinz; P Palma; A K Volkert; S Rothenhoefer; F Wenz; A Hochhaus; S Post; F Willeke
Journal:  Int J Colorectal Dis       Date:  2007-12-11       Impact factor: 2.571

10.  Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population.

Authors:  Sharon A Dobie; Joan L Warren; Barbara Matthews; David Schwartz; Laura-Mae Baldwin; Kevin Billingsley
Journal:  Cancer       Date:  2008-02-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.